Light Member on Vaccine Package for Viability and Visibility

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Farmers and veterinarians face challenges in administering vaccines effectively due to low light conditions and the inability to determine the viability of vaccines after reconstitution or removal from refrigerated storage, leading to potential improper administration and reduced vaccine effectiveness.

Innovation Solution

Packages with integrated light members that emit light upon activation, providing visibility and indicating the viability of the medicament through fluorescence or chemiluminescence, ensuring the medicament is used within its viable period.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Reliability

If vaccines are stored in refrigerated conditions and reconstituted, then vaccine viability is maintained initially, but the ability to determine ongoing viability becomes impossible

Engineering Contradiction:
Improvevaccine viability determinationVSAvoidviability information
Core Design Contradiction:
ReliabilityVSLoss of information

Solution Approach 1:

The patent employs color-changing indicators that transition from one color to another based on temperature exposure and time, providing visual feedback about vaccine viability. The color change mechanism allows farmers to immediately assess whether the vaccine remains effective without requiring laboratory equipment or complex testing procedures.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The patent introduces an intermediary indicator system that mediates between the vaccine's physical state and the farmer's ability to assess viability. This intermediary provides a clear, interpretable signal (color change, light emission) that bridges the gap between complex biochemical degradation processes and simple visual assessment.

Inventive Principle:
Principle #24Intermediary (Mediator)

2Ease of operation

If farmers administer vaccines in low light conditions, then vaccination can proceed in barn environments, but visibility of the vaccine bottle and septa becomes insufficient

Engineering Contradiction:
Improvevaccination administrationVSAvoidvisibility
Core Design Contradiction:
Ease of operationVSIllumination intensity

Solution Approach 1:

The patent incorporates light-emitting or light-reflective elements on the vaccine bottle and cap that are activated or become visible before the vaccination procedure begins. This preliminary illumination ensures that the bottle and critical components like the septa are easily locatable and identifiable in dark barn environments before the farmer needs to perform the injection.

Inventive Principle:
Principle #10Preliminary action

Solution Approach 2:

The patent uses high-visibility color markings and light-reflective surfaces on the vaccine packaging that enhance contrast and visibility under low-light conditions. These visual enhancements allow farmers to quickly locate and identify the correct vaccine bottle and its components without requiring strong ambient lighting.

Inventive Principle:
Principle #32Color changes

3Duration of action of moving object

If vaccines are used after the viable time period, then more time is available for administration, but vaccine effectiveness is reduced or eliminated

Engineering Contradiction:
Improveadministration time windowVSAvoidvaccine effectiveness
Core Design Contradiction:
Duration of action of moving objectVSReliability

Solution Approach 1:

The patent employs time-dependent color-changing indicators that transition at or near the expiration of the vaccine's viable period. This provides a clear visual warning to farmers before the vaccine becomes ineffective, allowing them to complete administration within the viable window without requiring complex timing calculations or memory.

Inventive Principle:
Principle #32Color changes

Solution Approach 2:

The patent implements a feedback mechanism through visual indicators that continuously communicate the vaccine's viability status to the farmer. This real-time feedback allows the farmer to adjust their administration schedule accordingly, ensuring the vaccine is used while effective without requiring active monitoring or record-keeping.

Inventive Principle:
Principle #23Feedback

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The light-activated packages enhance visibility under low light conditions and ensure the correct administration of vaccines by indicating when the medicament is no longer viable, thereby improving administration accuracy and vaccine effectiveness.

Implementation Method 1

the light member fluoresces or otherwise emits light to provide information to an end user

Methodology Applied
Scientific EffectFluorescence: Fluorescence

Implementation Method 2

the light generated by the light member may be configured such that it is emitted only for a time period equal to the viability time period of the medicament contained within the package

Methodology Applied
Scientific EffectChemiluminescence: Chemiluminescence

Data Source

PatentUS10549886B2Light member on a package to provide information to a user
Publication Date: 2020.02.04 BOEHRINGER INGELHEIM VETMEDICA GMBH
  • US10549886B2 patent drawing
  • US10549886B2 patent drawing
  • US10549886B2 patent drawing

AI summary

Packages that include at least one medicament therein include at least one light member affixed thereto that is capable of emitting light upon activation. The light member is activated upon the opening of the package such that, upon opening, the light member fluoresces or otherwise emits light to provide information to an end user. In some embodiments, the light generated by the light member allows the end user to locate the package in dark conditions. In other embodiments, the light generated by the light member may be configured to emit only for a time period equal to a viability time period of the medicament within the package or to change color at a time period equal to the viability time period of the medicament within the package to alert an end user that the medicament is no longer useable.